tiprankstipranks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market

Vir Biotechnology (VIR) Ownership - Who Owns Vir Biotechnology?

1,144 Followers

Vir Biotechnology (VIR) Ownership Overview

51.81%14.33%22.06%11.80%
51.81% Insiders
22.06% Other Institutional Investors
11.80% Public Companies and
Individual Investors
The ownership structure of Vir Biotechnology (VIR) stock is a mix of institutional, retail and individual investors. Approximately 36.39% of the company’s stock is owned by Institutional Investors, 51.81% is owned by Insiders and 11.80% is owned by Public Companies and Individual Investors.
The ownership structure of Vir Biotechnology (VIR) stock is a mix of institutional, retail and individual investors. Approximately 36.39% of the company’s stock is owned by Institutional Investors, 51.81% is owned by Insiders and 11.80% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 04, 2024
Marianne De Backer
Ceo,director
Sold$689803
Apr 02, 2024
Ann M. Hanly
Evp & Cto
Sold$27246
Mar 28, 2024
Sung Lee
Evp & Cfo
Sold$59359
Feb 26, 2024
Ann M. Hanly
Evp & Cto
Sold$123452

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Sold$243995

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,368,733Institution8.42%97,430,042
10,126,922Institution7.50%86,787,722
8,788,502Institution6.51%75,317,462
5,093,697Institution3.77%43,652,983
1,958,264Institution1.45%16,782,322
911,596Institution0.68%7,812,378
897,076Institution0.66%7,687,941
871,100Institution0.65%7,465,327
672,611Institution0.50%5,764,276
524,009Institution0.39%4,490,757

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
8,788,502Institution6.51%75,317,462
911,596Institution0.68%7,812,378
897,076Institution0.66%7,687,941
871,100Institution0.65%7,465,327
672,611Institution0.50%5,764,276
517,455Institution0.38%4,434,589
509,461Institution0.38%4,366,081
428,628Institution0.32%3,673,342
396,710Institution0.29%3,399,805
354,844Institution0.26%3,041,013

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,822,121Institution4.31%48,672,932
3,206,891Institution2.37%32,485,806
3,513,638Institution2.60%30,111,878
2,752,964Institution2.04%27,887,525
2,023,538Institution1.50%16,916,778
1,554,176Institution1.15%15,743,803
1,338,429Institution0.99%13,558,286
1,044,829Institution0.77%8,734,770
772,432Institution0.57%6,619,742
749,670Institution0.56%6,267,241

FAQ

Who Owns Vir Biotechnology (VIR)?
According to the latest TipRanks data, approximately 22.06% of the company's stock is held by institutional investors, 51.81% is held by insiders, and 11.80% is held by retail investors.
    What percentage of Vir Biotechnology (VIR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 22.06% of Vir Biotechnology (VIR) stock is held by institutional investors.
      What percentage of Vir Biotechnology (VIR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 11.80% of Vir Biotechnology (VIR) stock is held by retail investors.
        Who owns the most shares of Vir Biotechnology (VIR)?
        iShares owns the most shares of Vir Biotechnology (VIR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis